Posts

Australian High Court hears high-stakes matter of PTE eligibility of formulation patents

Otsuka seeks to appeal decision to deny PTEs for formulation patents in Australia

Formulation patents no longer eligible for PTE in Australia

When your formulation IP is beyond compare (T 0722/24)

No back-pedaling on prosecution disclaimers (Azurity v. Alkem, Fed. Cir. Case No. 23-1977)

BREAKING: Supreme Court confirms no hard line on inventive step test in finding Cialis dosage patent obvious

The rise of "obvious to try" is over as Court of Appeal finds CIALIS dosage regimen patent obvious

UPDATE: Birss J refuses permission to appeal in Genentech's Herceptin battle